1995
DOI: 10.1016/0020-2452(96)85762-9
|View full text |Cite
|
Sign up to set email alerts
|

Protective activities of serum immunoglobulin G on the mucosal surface to Vibrio cholerae O1

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
16
1
1

Year Published

2000
2000
2011
2011

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 21 publications
(19 citation statements)
references
References 27 publications
1
16
1
1
Order By: Relevance
“…Previous vaccine trials in Asia have shown that killed-cell Inaba vaccines protect against both serotypes, but Ogawa vaccines protect against only the homologous serotype (1). Similar results observed with serotype-specific mAbs tested for protective activity in neonatal mice (4)(5)(6) led to the conclusion that the Ogawa serotype contains a specific antigenic determinant, whereas the Inaba serotype contains a different antigenic determinant that crossreacts with the Ogawa serotype. The Ogawa serotype-specific epitope is probably associated with the upstream terminal perosamine residue of the O-SP, because Inaba strains are rfbT mutants of wild-type Ogawa strains in which methylation of the terminal perosamine is inactivated (2,3,7).…”
supporting
confidence: 62%
See 1 more Smart Citation
“…Previous vaccine trials in Asia have shown that killed-cell Inaba vaccines protect against both serotypes, but Ogawa vaccines protect against only the homologous serotype (1). Similar results observed with serotype-specific mAbs tested for protective activity in neonatal mice (4)(5)(6) led to the conclusion that the Ogawa serotype contains a specific antigenic determinant, whereas the Inaba serotype contains a different antigenic determinant that crossreacts with the Ogawa serotype. The Ogawa serotype-specific epitope is probably associated with the upstream terminal perosamine residue of the O-SP, because Inaba strains are rfbT mutants of wild-type Ogawa strains in which methylation of the terminal perosamine is inactivated (2,3,7).…”
supporting
confidence: 62%
“…Indeed, the S-20-4 Ab shows no detectable binding to the synthetic terminal mono-and oligosaccharides of the Inaba O-SP lacking the 2-O-methyl group (8). Also, the binding of IgG1 S-20-3 (same clone as S-20-4) to Ogawa LPS could not be inhibited by the Inaba O-SP (6). The central pocket is primarily defined by residues Tyr L32, Trp L91, and Trp L96 from the light chain and residues His H95 and Ala H98 from the heavy (Fig.…”
Section: Resultsmentioning
confidence: 96%
“…In our effort to develop a conjugate vaccine that targets V. cholerae O1 and O139, we have developed monoclonal antibodies specific to V. cholerae O1 or O139 LPS (4,5). Here we have exploited the specificity of the monoclonal antibodies to develop rapid diagnostic tests for cholera O1 or O139 using colloidal gold particles and based on a recently optimized (7) one-step, vertical-flow immunochromatography principle (13).…”
mentioning
confidence: 99%
“…PBS, pH 7.3 is a mixture of 0.05 M potassium phosphate buffer and 0.15 M NaCl. Mouse anti-LPS monoclonal Abs (mAbs), IgG I-24-2, F-22-30, and S-20-3 were prepared at the Institut Pasteur by immunizing mice with a lysate from V. cholerae O1 serotype Inaba [31][32][33]. Analytical and semi-preparative RP-HPLC separations were performed using a PerkinElmer Series 200 pump and a 785A UV/VIS detector system on a Kromasil C18 (A. I. T. chromato, France) (100 Å, 4.6×250 mm), column at a flow rate of 1 mL min −1 (monitoring and analysis), or on a Nucleosil 100-5 C18 (Macherey-Nagel) (100 Å, 5 μm, 10×250 mm) column, at a flow rate of 3 mL min −1 (semi-preparative), with detection at 215 nm.…”
Section: Methodsmentioning
confidence: 99%